XML 60 R45.htm IDEA: XBRL DOCUMENT v3.25.1
COLLABORATION AND LICENSING AGREEMENTS - Recognized Revenue (Details) - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2025
Mar. 31, 2024
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]    
Total revenues $ 74,114 $ 46,023
Licensing revenue    
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]    
Total revenues 5,020 17
Licensing revenue | Fosun Agreement | Fosun Pharma    
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]    
Total revenues 5,000 0
Licensing revenue | Knight Agreement | Knight    
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]    
Total revenues 20 17
Product supply revenue    
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]    
Total revenues 254 2,126
Product supply revenue | 2017 KKC Agreement | Kyowa Kirin    
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]    
Total revenues 0 2,126
Product supply revenue | Knight Agreement | Knight    
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]    
Total revenues 254 0
Non-cash royalty revenue related to the sale of future royalties    
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]    
Total revenues 1,026 368
Non-cash royalty revenue related to the sale of future royalties | 2017 KKC Agreement | Kyowa Kirin    
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]    
Total revenues $ 1,026 $ 368